Anatomic Pathology Market: Growth, Trends, Technologies, and Future Outlook
Pathology plays a role throughout the cancer-care pathway, including: Screening Diagnosis Tumor classification Staging Biomarker identification Treatment selection Monitoring Research The growing use of companion diagnostics and targeted therapies is further increasing the importance of pathology in oncology.
Farid Ilahi Shaikh The Anatomic Pathology Market is an essential segment of the global healthcare, medical devices, and biotechnology industry. Anatomic pathology focuses on the examination of tissues, organs, and biological specimens to identify diseases, determine their severity, and support treatment decisions. It plays a particularly important role in cancer diagnosis, where tissue examination can help determine tumor type, stage, biomarkers, and treatment options.
The market is evolving rapidly as healthcare providers move from conventional microscopy and manual laboratory workflows toward digital pathology, automated tissue processing, immunohistochemistry (IHC), molecular pathology, whole-slide imaging, and artificial intelligence (AI)-assisted analysis.
According to Kings Research, the global anatomic pathology market was valued at USD 38.24 billion in 2023 and is projected to increase from USD 40.79 billion in 2024 to USD 67.86 billion by 2031, registering a CAGR of 7.54% during the forecast period. The increasing incidence of cancer and chronic diseases, growing adoption of personalized medicine, and investments in advanced diagnostic infrastructure are among the primary factors supporting market growth.
Anatomic pathology is a medical specialty that examines tissues and organs to identify abnormalities associated with diseases. Samples can be obtained through biopsies, surgical procedures, autopsies, and other clinical interventions.
Pathologists examine these samples using a combination of techniques, including:
- Gross examination
- Histopathology
- Cytopathology
- Histochemical staining
- Immunohistochemistry
- In situ hybridization
- Molecular testing
- Digital pathology
- AI-assisted image analysis
The information generated through these techniques can help physicians understand disease characteristics and determine appropriate treatment strategies.
Anatomic pathology is especially important in oncology because tissue-based analysis can distinguish between benign and malignant lesions and provide information needed for cancer classification and treatment planning.
Major Growth Drivers of the Anatomic Pathology Market
Rising Global Cancer Burden
The increasing prevalence of cancer is one of the most important drivers of the anatomic pathology industry.
Cancer diagnosis frequently requires examination of tissue samples to confirm malignancy, classify tumors, determine disease progression, and identify biomarkers that may influence treatment selection.
The World Cancer Research Fund reported approximately 19.98 million new cancer cases in 2022, highlighting the substantial global need for cancer diagnostic services.
As cancer screening programs expand and diagnostic technologies become more accessible, demand for pathology testing is expected to increase.
Growing Adoption of Personalized Medicine
Personalized medicine is transforming the role of pathology in healthcare.
Rather than relying only on conventional disease classification, clinicians increasingly require detailed information about molecular and biological characteristics to select treatments for individual patients.
Anatomic pathology contributes to this process by identifying biomarkers and other tissue characteristics that can help determine whether a patient may benefit from targeted therapies.
The growing use of targeted cancer treatments and companion diagnostics is therefore increasing demand for advanced pathology technologies.
Increasing Demand for Early Disease Diagnosis
Early diagnosis can improve treatment planning and patient outcomes across many diseases.
Healthcare providers are therefore investing in diagnostic infrastructure capable of processing tissue samples quickly and accurately.
Clinical laboratories are increasingly adopting automated tissue processors, slide scanners, staining systems, and digital pathology platforms to improve workflow efficiency.
Kings Research expects the clinical laboratories segment to grow at a CAGR of approximately 8.44% during the forecast period.
Anatomic Pathology Products and Services
The market can broadly be divided into services, consumables, and instruments.
Anatomic Pathology Services
Pathology services include the preparation, examination, interpretation, and reporting of tissue specimens.
Services are widely provided by:
- Hospital laboratories
- Independent clinical laboratories
- Diagnostic centers
- Research institutions
- Specialized pathology networks
Kings Research identifies services as the leading product and service segment, generating approximately USD 16.65 billion in 2023.
Outsourcing pathology services can allow healthcare organizations to access specialized expertise and advanced diagnostic capabilities without investing extensively in their own infrastructure.
Consumables
Consumables represent an essential component of pathology workflows.
These include:
- Reagents
- Antibodies
- Stains
- Dyes
- Fixatives
- Tissue-embedding materials
- Microscope slides
- Coverslips
- Probes
- Diagnostic kits
The increasing number of pathology tests performed worldwide creates recurring demand for consumables.
The development of more specialized antibodies, molecular probes, and diagnostic reagents is also expanding the range of diseases and biomarkers that can be evaluated.
Instruments
Anatomic pathology laboratories rely on a wide range of instruments, including:
- Tissue processors
- Microtomes
- Cryostats
- Slide stainers
- Coverslippers
- Microscopes
- Slide scanners
- Imaging systems
Automation is becoming increasingly important because laboratories must process growing sample volumes while maintaining consistent quality.
Histopathology
Histopathology is one of the foundational technologies within anatomic pathology.
It involves microscopic examination of tissue sections to identify structural abnormalities associated with disease.
The process generally includes:
- Tissue collection
- Fixation
- Tissue processing
- Embedding
- Sectioning
- Staining
- Microscopic examination
- Diagnosis and reporting
Hematoxylin and eosin (H&E) staining remains a fundamental technique for evaluating tissue morphology.
Although newer molecular and digital technologies are expanding pathology capabilities, conventional histopathology remains central to clinical diagnosis.
Immunohistochemistry
Immunohistochemistry (IHC) uses antibodies to detect specific proteins or biomarkers within tissue samples.
IHC is particularly important in oncology because specific biomarkers can help identify tumor types and determine whether certain targeted therapies may be appropriate.
The technology can also assist with disease classification and prognosis.
Recent market data indicates strong growth in IHC, with the global IHC segment estimated at approximately USD 8.12 billion in 2025 and projected to grow at a CAGR of 9.4% from 2025 to 2033.
The continued development of highly specific antibodies and automated staining platforms is expected to support this segment.
Digital Pathology Transforming Traditional Workflows
Digital pathology is one of the most significant technological trends in the market.
Instead of relying exclusively on physical microscope slides, laboratories can scan tissue slides and convert them into high-resolution digital images.
Digital pathology enables pathologists to:
- View slides remotely
- Share cases electronically
- Collaborate across locations
- Store digital images
- Compare historical samples
- Integrate image analysis software
- Support AI-assisted diagnosis
The global digital pathology segment generated approximately USD 4.88 billion in revenue in 2025 and is projected to grow at a CAGR of 12.7% from 2025 to 2033, according to Grand View Research.
This growth rate highlights the increasing importance of digital transformation within pathology laboratories.
Artificial Intelligence in Anatomic Pathology
AI is emerging as a powerful tool for pathology image analysis.
Machine-learning algorithms can analyze digital tissue images to identify patterns that may be difficult or time-consuming to evaluate manually.
Potential AI applications include:
- Tumor detection
- Tissue classification
- Cell counting
- Biomarker quantification
- Cancer grading
- Image segmentation
- Diagnostic decision support
AI is generally being developed as a tool to assist pathologists rather than completely replace them.
The combination of human expertise and AI-based image analysis could improve workflow efficiency and help laboratories handle increasing workloads.
Molecular Pathology
Molecular pathology combines tissue analysis with molecular diagnostic techniques.
Methods such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH) can provide information about genetic and molecular abnormalities.
These techniques are becoming increasingly relevant to precision oncology.
For example, identifying specific genetic alterations can help physicians select targeted therapies for certain cancers.
The integration of molecular information with conventional histopathology is creating increasingly comprehensive diagnostic workflows.
Medical Research Applications
Anatomic pathology is not limited to clinical diagnosis.
It also plays an important role in medical research, drug discovery, and clinical trials.
Researchers use tissue analysis to:
- Study disease mechanisms
- Evaluate drug responses
- Identify biomarkers
- Assess treatment effectiveness
- Study tumor characteristics
- Develop new therapies
According to Kings Research, medical research accounted for 64.76% of the market in 2023, making it the leading application segment.
The increasing development of targeted therapies and biologic drugs is expected to sustain demand for advanced tissue-analysis technologies.
Oncology Remains a Major Application
Cancer is one of the most important application areas for anatomic pathology.
Pathology plays a role throughout the cancer-care pathway, including:
- Screening
- Diagnosis
- Tumor classification
- Staging
- Biomarker identification
- Treatment selection
- Monitoring
- Research
The growing use of companion diagnostics and targeted therapies is further increasing the importance of pathology in oncology.
As cancer treatment becomes more personalized, pathology laboratories will increasingly need integrated capabilities covering morphology, immunohistochemistry, and molecular testing.
Infectious Disease Applications
Anatomic pathology also contributes to the diagnosis of infectious diseases.
Tissue analysis can help identify pathological changes caused by:
- Bacteria
- Viruses
- Fungi
- Parasites
The emergence and re-emergence of infectious diseases is increasing demand for accurate diagnostic methods.
Governments and healthcare organizations are investing in laboratory infrastructure and diagnostic capabilities to improve disease detection and outbreak response.
Hospital and Clinical Laboratories
Hospital laboratories are major users of anatomic pathology technologies.
Hospitals require pathology services to support surgery, oncology, transplantation, emergency care, and other medical specialties.
Clinical laboratories are also becoming increasingly important as healthcare systems expand centralized testing and outsourcing models.
Modern laboratories are investing in automation and digital systems to improve sample throughput, reduce manual errors, and shorten turnaround times.
Automation in Pathology Laboratories
Laboratory automation is becoming increasingly important as pathology workloads increase.
Automated systems can support multiple stages of the workflow, including:
- Tissue processing
- Embedding
- Sectioning
- Staining
- Coverslipping
- Slide scanning
- Image analysis
Automation can improve standardization and reduce repetitive manual work.
It can also help laboratories address workforce shortages by allowing skilled professionals to focus on complex diagnostic tasks.
Telepathology and Remote Diagnosis
Digital pathology enables pathologists to review tissue samples remotely.
Telepathology can be particularly useful when specialized expertise is unavailable locally.
A digital slide can be shared securely with another pathologist for consultation, second opinions, or multidisciplinary case discussions.
This capability can improve access to specialized pathology expertise and support collaboration between hospitals and laboratories.
Cloud-Based Pathology Platforms
Cloud computing is increasingly being incorporated into digital pathology workflows.
Cloud-based platforms can support:
- Digital slide storage
- Remote access
- Collaboration
- Data management
- AI processing
- Multi-site laboratory networks
However, cloud deployment must address cybersecurity, patient privacy, regulatory compliance, and data-storage requirements.
North America Market Outlook
North America remains a major region for the anatomic pathology industry.
Recent market research estimates that North America accounted for approximately 38.8% of global anatomic pathology revenue in 2025.
The region benefits from:
- Advanced healthcare infrastructure
- High healthcare expenditure
- Strong cancer diagnostic capabilities
- Rapid adoption of digital pathology
- Established clinical laboratory networks
- Presence of major medical technology companies
The United States is particularly important because of its extensive pathology and oncology infrastructure.
Europe Market Outlook
Europe represents another significant market for anatomic pathology.
The region benefits from established healthcare systems, cancer screening programs, medical research institutions, and growing adoption of digital diagnostics.
The UK, Germany, France, Italy, and Spain are among the important markets.
Healthcare digitization initiatives and investments in precision medicine are expected to encourage adoption of digital pathology and molecular diagnostic technologies.
Asia Pacific Market Outlook
Asia Pacific is expected to offer substantial growth opportunities.
Countries such as China, India, Japan, South Korea, and Australia are increasing healthcare investments and expanding diagnostic infrastructure.
Large patient populations, increasing cancer incidence, growing healthcare awareness, and expansion of hospital and laboratory networks are supporting market development.
China and India are particularly attractive markets because of their large populations and expanding diagnostic capabilities.
The adoption of digital pathology and AI-based solutions could also help address disparities in access to specialized pathology expertise.
Challenges Facing the Anatomic Pathology Market
Despite strong growth opportunities, the industry faces several challenges.
High Cost of Digital Pathology Systems
Whole-slide scanners, image-management platforms, storage infrastructure, and AI software can require substantial investment.
This can make digital transformation difficult for smaller laboratories and healthcare facilities with limited budgets.
Shortage of Skilled Pathologists
The increasing volume and complexity of diagnostic cases creates pressure on pathology professionals.
Laboratories are therefore increasingly exploring automation, AI-assisted analysis, centralized testing, and remote consultation.
Data Management and Storage
Digital pathology generates very large image files.
Healthcare providers need reliable storage infrastructure, efficient data-management systems, and secure backup solutions.
Regulatory and Data Privacy Requirements
Pathology data contains sensitive patient information.
Digital systems must therefore comply with applicable healthcare, privacy, cybersecurity, and medical-device regulations.
Diagnostic Complexity
Modern pathology increasingly requires integration of morphology, immunohistochemistry, and molecular information.
Laboratories must therefore invest in both technology and specialized expertise to deliver comprehensive diagnostic services.
Sustainability in Anatomic Pathology
Sustainability is becoming increasingly relevant to modern laboratories.
Pathology workflows generate biological waste, chemical waste, plastic consumables, and large amounts of packaging.
Laboratories are exploring ways to improve resource efficiency through:
- Automated workflows
- Digital reporting
- Reduced paper use
- Energy-efficient instruments
- Optimized reagent consumption
- Better waste management
Digital pathology can also reduce the need to physically transport slides between facilities in certain workflows, potentially improving efficiency.
Competitive Landscape
The global anatomic pathology market includes major healthcare and medical technology companies such as F. Hoffmann-La Roche Ltd., Danaher Corporation, PHC Holdings Corporation, Agilent Technologies, Cardinal Health, Quest Diagnostics, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, BioGenex, and Sakura Finetek USA.
Companies are focusing on:
- Digital pathology
- AI-based image analysis
- Automated laboratory systems
- Immunohistochemistry
- Molecular diagnostics
- Workflow integration
- Strategic partnerships
- Product launches
- Acquisitions
The competitive environment is increasingly shifting toward integrated pathology ecosystems rather than individual instruments or reagents.
Future Trends in the Anatomic Pathology Market
AI-Assisted Diagnosis
AI is expected to become increasingly integrated into digital pathology platforms for image analysis, tumor detection, grading, and biomarker quantification.
Digital Pathology Expansion
The shift from physical slides toward digital workflows is expected to continue as scanning technology becomes more affordable and healthcare organizations become more comfortable with digital diagnosis.
Integrated Molecular Pathology
Combining tissue morphology with molecular information will become increasingly important in precision medicine.
Remote Pathology
Telepathology and cloud-based platforms could expand access to specialized pathology expertise, particularly in regions with limited numbers of trained specialists.
Personalized Cancer Treatment
The growing importance of biomarkers and targeted therapies will increase demand for sophisticated pathology testing.
Laboratory Automation
Automation will become increasingly important for improving throughput, consistency, and operational efficiency.
Conclusion
The Anatomic Pathology Market is undergoing a major transformation as rising disease prevalence intersects with advances in digital imaging, automation, molecular diagnostics, and artificial intelligence.
According to Kings Research, the global market is projected to grow from USD 40.79 billion in 2024 to USD 67.86 billion by 2031, representing a CAGR of 7.54%.
The growing global cancer burden remains one of the strongest drivers of demand, while personalized medicine is increasing the need for detailed tissue and biomarker analysis. Services currently represent a major part of the market, while medical research remains a significant application area.
At the technology level, digital pathology, immunohistochemistry, molecular pathology, automation, and AI-assisted image analysis are expected to shape the next phase of industry development. Digital pathology in particular is becoming an important foundation for remote diagnosis, computational pathology, and AI integration.
North America is expected to remain a leading market, while Asia Pacific offers substantial growth potential due to expanding healthcare infrastructure, increasing disease burden, and rising adoption of advanced diagnostic technologies.
Overall, the future of anatomic pathology will be defined by the transition from traditional microscope-based workflows toward connected, automated, digital, molecular, and AI-enabled pathology ecosystems. This transformation is expected to improve diagnostic efficiency, expand access to specialized expertise, and support the continued development of precision medicine.
